Conferences and Meetings on Pharmacology and Drug Development

Conference-Service.com offers, as part of our business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events. Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!

Meeting organisers can submit meetings free of charge for inclusion into the listing.

ALL COUNTRIES

1.
 
Biosimilars Congress India 2016
ID
818119
Dates
01 Sep 2016 - 02 Sep 2016
Location
Hyderabad, India
Contact
Drashti Shah;     Email: drashti.shah@ubm.com
Topics
Regulatory expectations for Biosimilars in US, EU and Japan, Updates on the recent CDSCO Guidelines released on 26th March 2016, Domestic food-beverage manufacturers and suppliers, Identifying critical quality attributes of innovator reference products, Statistical analysis to determine biosimilarity, Assessing the Quality and CMC consideration for biosimilars
2.
 
10th Vaccine Congress
ID
800403
Dates
04 Sep 2016 - 07 Sep 2016
Location
Amsterdam, Netherlands
3.
 
IIR-cryobio-workshop — IIR Workshop on Cold Applications in Life Sciences
ID
789109
Dates
08 Sep 2016 - 09 Sep 2016
Location
Dresden, Germany
Abstract
Cell/tissue cryopreservation and cold storage are central challenges e.g. in biobanking. Freezing and cryoprocessing are becoming increasingly important as an essential production step in life sciences, too.
Contact
Dr. Gabriele Spoerl;     Phone: [+49 351 4081 604];     Email: gabriele.spoerl@ilkdresden.de; CryoWorkshop2016@ilkdresden.de
Topics
Cell/tissue cryopreservation and storage challenges: advanced devices for cryopreservation and freeze-drying, cryobanking of biologicals, 3D-scaffolds / tissue engineering for medical and diagnostic applications, strategies with alternative cryoprotectants for tissues cryopreservation, industrial solutions in biomaterial processing. Freezing and storage of active agents for in-vitro and in-vivo applications: damage processes on active agents caused by cold application, process limitations and impact factors on product stability, process validation – analytics, monitoring and simulation of process and product loss, vitrification of cellular products without cryoprotectants, industrial freezing solutions - large scale and multi-product plant.
Related subject(s)
4.
 
11th Drug Design & Medicinal Chemistry Conference
ID
806650
Dates
12 Sep 2016 - 13 Sep 2016
Location
Boston, United States
Abstract
We invite you to attend the 11th Drug Design & Medicinal Chemistry Conference, which will take place September 12-13, 2016 in Boston, MA. This meeting will provide a forum for scientists across multiple disciplines, from both industry and academia, to connect and share complementary perspectives. We will discuss emerging target classes, advances in antibody drug conjugates and other methods for targeted drug delivery, new approaches in flow chemistry, and much more. In addition to scientific presentations, we will have dedicated times for networking among delegates.
Contact
Kristen Starkey;     Phone: [6262566405];     Email: infogtcbio@gtcbio.com
Topics
Drug Design, Medicinal Chemistry
5.
 
2016 Pharma CI USA Conference & Exhibition
ID
807082
Dates
13 Sep 2016 - 14 Sep 2016
Location
Parsippany, NJ, United States
Abstract
The Best and Largest Assembly of Pharmaceutical Competitive Intelligence Executives! The 2016 Pharma CI USA Conference & Exhibition (Sept. 13-14, 2016, Parsippany, NJ) is the industry's gold standard for senior level pharma, biotech, and medical device professionals who seek the latest in competitive and business intelligence.
Contact
Ross Frasier;     Email: ross@pharmaciconference.com
Topics
pharma, pharmaceutical, biopharma, competitive intelligence, business intelligence
6.
 
Precision: Lung Cancer World Summit 2016
ID
823627
Dates
13 Sep 2016 - 14 Sep 2016
Location
Boston, United States
Abstract
The summit will cover the latest updates from the pipelines of small and large drug developers, and feature discussions around the latest trends in precision medicine through case studies from early discovery to development.
Contact
Grace Hamilton;     Phone: [+1 617.500.5172];     Email: grace@neo-synth.com
Topics
Antibody Drug Conjugates, Immuno-Oncology, Biomarkers / Companion Diagnostics
Related subject(s)
7.
 
BPA — BioPharm America™ 2016—9th Annual International Partnering Conference
ID
795826
Dates
13 Sep 2016 - 15 Sep 2016
Location
Boston, United States
Abstract
Beginning its ninth year as an industry event, BioPharm America™ creates a robust exchange among hundreds of executives from venture capital firms, major pharmaceutical companies, academic institutions and biotechnology companies of every size from mature to startup. The event brings dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development.
Topics
partnering, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, finance
8.
 
BEU — BIO-Europe® 2016 - 22nd Annual International Partnering Conference
ID
820049
Dates
13 Sep 2016 - 15 Sep 2016
Location
Boston, United States
Abstract
The 22nd annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 3,500 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward.
Contact
Camille Del Carmen;     Phone: [+1 760 930 0500];     Email: cdelcarmen@ebdgroup.com
Topics
partnering, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, finance, life science
Related subject(s)
9.
 
Virtue Insight — 5th Annual Pharma Anti Counterfeiting & Serialisation 2016
ID
828608
Dates
14 Sep 2016 - 15 Sep 2016
Location
chennai, India
Contact
Amardeep;     Phone: [4464536444];     Email: amar@virtueinsight.co.in
10.
 
4th GPCR in Drug Discovery Conference
ID
812608
Dates
14 Sep 2016 - 15 Sep 2016
Location
Boston, United States
Abstract
We invite you to attend the 4th GPCR in Drug Discovery Conference, which will take place September 14-15, 2016 in Boston, MA. G protein-coupled receptors are the largest family of protein receptors and account for one of the largest classes for drug targets currently in the market. Continued breakthrough and insights into the structural biology of GPCRs have opened up greater potential of this target class to impact drug discovery and renewed interest in this field.
Contact
Kristen Starkey;     Phone: [6262566405];     Email: infogtcbio@gtcbio.com
Related subject(s)
11.
 
MUCOVAD 2016 — Mucosal Vaccines, Adjuvants & Delivery
ID
762122
Dates
14 Sep 2016 - 16 Sep 2016
Location
Lausanne, Switzerland
Abstract
MUCOVAD 2016 will be an opportunity for researchers to hear updates on new developments in the area of mucosal vaccines and associated adjuvantation and delivery mechanisms/platforms
12.
 
2016 Pharmacology Update
ID
832642
Start date
16 Sep 2016
Location
Kansas City, United States
Abstract
The 2016 Pharmacology Update will focus on clinical decision-making in prescribing pharmacologic interventions for common disease conditions encountered in primary care settings. Presentations related to common generic medications, anti-hypertensives, lipid lowering agents, psychopharmacologic drugs, anti-infectives and respiratory medications are designed to reinforce cost-effective and clinically appropriate choices, emphasizing safe prescribing practices. In addition, common clinical issues and concerns related to drug allergies, adverse effects and drug interactions will be presented.

Presented by the University of Missouri-Kansas City School of Nursing and Health Studies

Contact
Laney Beaman;     Email: beamanl@umkc.edu
13.
 
4th Antivirals Congress
ID
801166
Dates
18 Sep 2016 - 21 Sep 2016
Location
Barcelona - Sitges, Spain
Abstract
The key objectives of these unique interdisciplinary conferences are:  To enable researchers from around the world to present important new findings;,  To highlight recent advances in drug and vaccine development, from basic science through clinical trials,  To publicize novel techniques that will speed the pace of research;,  To facilitate interdisciplinary collaborations, by providing opportunities for networking among laboratory scientists, clinicians and public health officials.. Meeting sessions will focus on new antiviral drugs, novel approaches to preventive and therapeutic vaccines, structural studies of viral proteins, antiviral drug resistance, emerging viruses and other topics.  The Congresses are sponsored by Antiviral Research, a journal for research on the prevention and treatment of viral diseases, now in its 35th year of publication. 
Related subject(s)
14.
 
cGMP WORKSHOP 2016
ID
823673
Dates
19 Sep 2016 - 20 Sep 2016
Location
Mumbai, India
Abstract
cGMP being the most important component in assuring pharmaceutical quality, consumers expect that each batch of medicine they consume meets the stipulated quality standard. However most of the drug manufacturers are either not aware of these cGMPs, or unaware of how FDA assures that drug manufacturing processes meet these basic objectives. This has in return resulted in the rising trend of warning letters over the past couple of years due to cGMP issues.

Considering the need to address this challenge, CPhI is announcing the first ever specialised training on cGMP taking place in September at Mumbai. This two day exclusive training will be conducted by Former US F.D.A trainer who would help companies to prevent instances of contamination, mix-ups, deviations, failures and errors to successfully meet the desired quality standards.

Contact
Mumbai;     Phone: [2261727077];     Email: purvai.gupta@ubm.com
15.
 
Bioplasma — 5th Annual Bioplasma World Asia 2016
ID
827100
Dates
19 Sep 2016 - 21 Sep 2016
Location
Hong Kong, China
Abstract
Bioplasma World 2016 has achieved a record breaking success by increasing participation by 30% from 2014, and the 5th Annual Bioplasma World Asia has firmly established itself as the most definitive and most important annual meeting place for the plasma products industry year after year!
Contact
Andrew Darwitan;     Phone: [+65 3109 0156];     Email: andrew.darwitan@imapac.com
Related subject(s)
16.
 
DOT — 14th Annual Discovery on Target
ID
806837
Dates
19 Sep 2016 - 22 Sep 2016
Location
Boston, MA, United States
Abstract
Cambridge Healthtech Institute will host the 14th Annual Discovery on Target event this September 19-22, 2016 in Boston, MA. Spanning four days, the event showcases current and emerging “hot” targets for the pharmaceutical industry. Over 1,100+ attendees (from 26 countries) composed of scientists/technologists, executives, directors, and managers from biopharma, academic, and healthcare organizations participate annually. The 2016 event is comprised of 17 conference tracks, 1 training seminar, 5 symposia, 16 short courses, an exhibit hall of 50+ companies, 135+ posters, and dedicated networking sessions. Discovery on Target assembles an impressive group of 300+ distinguished speakers who look forward to sharing their knowledge, best practices, and expertise with all attendees.
Contact
Phone: [7819725400];     Email: chi@healthtech.com
Topics
drug discovery, drug development, pharma, diseases, genomics, cancer
Related subject(s)
17.
 
EYE — 4th Annual Targeting Ocular Disorders
ID
806869
Dates
20 Sep 2016 - 21 Sep 2016
Location
Boston, MA, United States
Abstract
With its complex structure and the breadth of ocular disorders, the eye presents unique challenges to drug discovery. Cambridge Healthtech Institute’s fourth annual Targeting Ocular Disorders conference provides a platform to discuss novel targets and disease pathways, the latest drug delivery methods, and the most promising emerging therapies. A special focus will be on gene therapy, stem cell therapies, and treatments outside of the well-established anti-VEGF therapies. The event will cover a broad range of diseases including but not limited to glaucoma, wet and dry age‐related and diabetic macular degeneration, retinopathy and retinitis pigmentosa.
Contact
Phone: [7819725400];     Email: chi@healthtech.com
Topics
ophthalmology, retinal diseases, gene therapy, ocular disorders, drug delivery, stem cells
Related subject(s)
18.
 
ABK — PEGS Korea 2016: The Essential Protein Engineering Summit
ID
806846
Dates
20 Sep 2016 - 22 Sep 2016
Location
Seoul, South Korea
Abstract
From the earlier regulatory successes of Adcetris® and Kadcyla® to the recent FDA approval of Blincyto®, to the current clinical successes of Opdivo® and Keytruda®, the industry is abuzz with excitement and new hope. The successes of antibody-drug conjugates, bispecific antibodies and immunotherapy drugs and combinations are opening new doors for biotech companies to discover and develop breakthrough remedies.
Contact
Phone: [7819725400];     Email: chi@healthtech.com
Topics
protein engineering, antibody engineering, cancer immunotherapy
19.
 
Cell & Gene Therapy Europe
ID
820703
Dates
21 Sep 2016 - 22 Sep 2016
Location
Berlin, Germany
Abstract
Be part of the only cell and gene therapy event to offer commercial, regulatory, supply chain and R&D insight to ensure next-generation ATMP success. Phacilitate have assembled a unique speaker list that brings together all the key voices in the cell and gene therapy sector including Big Pharma, biotech, VCs, HTAs, payers and regulators.
Contact
Carina Hunter;     Phone: [+44(0)2073847897];     Email: team@phacilitate.co.uk
Topics
gene therapy, regulatory, supply chain, R&D, ATMP, cell biology
20.
 
Immunotherapy Europe
ID
820713
Dates
21 Sep 2016 - 22 Sep 2016
Location
Berlin, Germany
Abstract
Be part of the only immuno-oncology event to combine business, R&D, partnering and regulatory sessions to give attendees the vital big picture. Phacilitate have assembled a unique speaker panel with a holistic approach to covering oncology combination immunotherapy strategy development. Hear from all the key stakeholders within the immuno-oncology space including Big Pharma, biotech, payers, HTAs, regulators and leading investors. Co-located alongside Cell & Gene Therapy Europe, join 350+ senior executives from across the cell, gene and immunotherapy space. With 77% Director-level and above, this is the place to meet new partners and collaborators to achieve next-generation immuno-oncology success.
Contact
Carina Hunter;     Phone: [+44(0)2073847897];     Email: team@phacilitate.co.uk
Topics
immunotherapy, oncology, regulatory session, cancer research, big pharma, biotech, payers, HTAs, regulators, leading investors
21.
 
Cancer Vaccines
ID
809618
Dates
21 Sep 2016 - 22 Sep 2016
Location
London, United Kingdom
Abstract
Aimed at an audience of senior scientists and oncology specialists involved in targeted vaccines and drug research, Cancer Vaccines 2016 will provide a perfect platform to discuss pioneering clinical developments and the next generation of cancer immunotherapy. The 5th annual show will capture expert insight by honing in on new pathways with novel vaccines and immunotherapies, drug formulations, personalised treatment, immune check-point inhibitors, plus more
Contact
Teri Arri;     Phone: [+442078276000];     Email: tarri@smi-online.co.uk
Topics
Cancer vaccines; combination cancer immunotherapy; CAR, T-Cell; Dendritic Cells; Epitopes, Cancer, vaccine, combination therapies, adjuvants, chimeric antigen receptors, cells, immunotherapies, tumour, efficacy, delivery, therapeutic vaccines, immune monitoring, PDL-1, CTLA4, monoclonal antibodies, conference, London; tumour, immune, genetic heterogeneity, angiogenic, immune-oncology, oncology, rna, immunogen, immune, personalized therapy, protein, biomarker, disease, novel pathway, molecular, vaccinology, cell-based, liposomes, dna, peptide, vaccine
Related subject(s)
22.
 
Virtue Insight — 9th Biosimilars Congregation 2016
ID
828585
Start date
22 Sep 2016
Location
Mumbai, India
Contact
Amardeep;     Phone: [4464536444];     Email: amar@virtueinsight.co.in
23.
 
12th Annual Quality in Pharma & Biotech
ID
811839
Dates
22 Sep 2016 - 23 Sep 2016
Location
Vienna, Austria
Abstract
This event will exploit the importance of shifting from a culture of compliance to a culture of quality and improvement. Get updated on FDA- /EMA hot topics and how they are implemented by the industry. Explore how to make your processes more efficient and achieve a lean & cost-passive QA and QC.
Contact
Andrea Weber;     Phone: [+421 257 272 145];     Email: andrea.weber@fleming.events
Topics
Culture of quality & change management, Lean quality, Quality metrics, GMP inspection observations, warning letters and consent decrees, ISO IDMP, Critical quality considerations for serialization, Data integrity, CMO quality oversight, Quality risk management, Technology transfer
Event website
24.
 
SIPCD 2016 — 4th Symposium on Innovative Polymers for Controlled Delivery
ID
800351
Dates
23 Sep 2016 - 26 Sep 2016
Location
Suzhou, China
Event website
25.
 
Chemical biology approaches to assessing and modulating mitochondria
ID
776887
Dates
26 Sep 2016 - 27 Sep 2016
Location
The Royal Society at Chicheley Hall, Buckinghamshi, United Kingdom
Abstract
Mitochondria are central to many current biomedical problems. In these, variations in chemical processes are critical, but progress in understanding these and in developing therapies has been hampered by lack of methods to measure and manipulate mitochondrial 'chemistry'. This meeting will explore the interface of chemical biology and mitochondrial studies to open up new avenues for research and therapeutic interventions.
Contact
Naomi Asantewa-Sechereh;     Phone: [+442074512515];     Email: kavli.events@royalsociety.org
Topics
redox signalling, Reactive oxygen species (ROS), oxidative damage, mitochondria, mitochondrial therapies
Related subject(s)
26.
 
14th Annual Pharma IT Congress
ID
787558
Dates
28 Sep 2016 - 29 Sep 2016
Location
London, United Kingdom
Abstract
Oxford Global are proud to present the 14th Annual Pharmaceutical IT Congress, taking place on 28 – 29 September 2016 in London, UK. This highly established event will focus on exciting Big Data implementation case studies, novel research results in translational informatics, updates in data management for Real-World Evidence and novel IT solutions. The pharmaceutical IT industry represents a complex area of research that is under continuous pressure to develop novel solutions to improve its performance. Thanks to recent advancements in cloud computing solutions, Real-World Data and analytics, the industry is flourishing.
Contact
Guillaume Alonso;     Phone: [+44 (0)1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Topics
Over 200 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions Over 40 presentations and case studies focusing on the key developments in Big Data, Translational Informatics, Data Management for Real-World Evidence and IT Solutions Including 4 interactive streams: - Utilising Big Data In R&D - Translational Informatics - Data Management For Real-World Evidence - Novel IT Solutions
Related subject(s)
27.
 
ICONAN 2016 — International Conference On Nanomedicine And Nanobiotechnology
ID
785090
Dates
28 Sep 2016 - 30 Sep 2016
Location
Paris, France
Abstract
The target is to set up one of the most attractive international annual gatherings of experts from all around the world, in order for them to exchange about their latest research results and share their ideas.
Contact
ICONAN 2016 Organizing Committee;     Phone: [0033781201182];     Email: iconan2016@premc.org
Topics
Targeted drug delivery and nanocarriers, Nanomedicine for cancer diagnosis & therapy, Biological & medical nanodevices and biosensors, Tissue engineering and regenerative nanomedicine, Toxicology and risk assessment of nanomedicine systems, Nano-Imaging for diagnosis, therapy and delivery, Bionanocatalysis and nanobisystems, Microfluidics in nanomedicine and nanobiology.
Related subject(s)
28.
 
Process Scale-Up in the Pharmaceutical Industry
ID
821832
Dates
29 Sep 2016 - 30 Sep 2016
Location
Prague, Czech Republic
Abstract
The major objective of this course is to provide a detailed insight into the practical aspects and approaches of process scale-up for different unit operations and technologies. Scale-Up process deals with a vitally important subject for the pharmaceutical industry in addressing the procedures of transferring the results of R&D obtained on laboratory scale to the pilot plant and finally to production scale.
Contact
Andrea Weber;     Phone: [+421257272145];     Email: andrea.weber@fleming.events
Topics
QbD Principles during Process Development and Scale-Up, Scale-Up and Process validation for oral Pharmaceuticals and Biologics, Wet Granulation and the Compression Process, Regulatory compliance for biologics and NCEs, Common scale-up issues and Troubleshooting
29.
 
Biosimilars Europe
ID
809542
Dates
29 Sep 2016 - 30 Sep 2016
Location
London, United Kingdom
Abstract
SMi Group is thrilled to present the 7th annual conference, Biosimilars Europe , taking place on 29th & 30th September 2016 in Central London, UK. Gathering an audience of principle scientists and regulatory experts involved in biotechnology and compliance, Biosimilars Europe 2016 will provide a perfect platform to discuss global market developments and strategies to market access. Created with a top panel of industry thought leaders, this year's event will capture expert insight by honing in on the biosimilar product life-cycle from early stage developments, protein characterisation, and pricing & reimbursement; through to emerging markets and global developments. Join us this autumn to arm yourself with the key requirements and tools for successful market entry through strategic direction on commercialisation; insight into potential therapeutic areas; and guidance on product quality assessment (PQA) in biosimilar development. The notable speaker line-up includes: Boehringer Ingelhei, Merck, Lupin Ltd, Bristows, Austrian Agency for Health and Food Safety + many more!
Contact
Teri Arri;     Phone: [+442078276000];     Email: tarri@smi-online.co.uk
Topics
biosimilars, biobetters, conference, regulatory, patent, us market, generics, pricing and reimbursement, market access, commercialisation, EU, global developments, emerging markets, pharmacovigilance, protein characterisation, analytical comparability, approval, immunogenicity, pqa, product quality assessment, comparative analysis, pricing and reimbursement, p&r, litigation, , European regulation, biogenerics, IP, intellectual property, data protection, supplementary protection certificate, payer
30.
 
ADDCIn16 — Antibodies and Antibody Drug Conjugates
ID
812361
Dates
29 Sep 2016 - 30 Sep 2016
Location
Bengaluru, India
Abstract
SELECTBIO brings to you its 2nd International conference on ADC Development & Manufacture
Contact
SelectBio India;     Phone: [7696225050];     Email: sb.jatinkashyap@gmail.com
Topics
ADC Development - Issues and Challenges, Antibody Engineering for ADCs, Bioanalytical Strategies for ADCs, Novel Conjugation Technologies, Payload & Linkers, Strategies Development of Specific and Targeted ADCs.
31.
 
DDindia16 — Drug Discovery India 2016
ID
812360
Dates
29 Sep 2016 - 30 Sep 2016
Location
Bengaluru, India
Abstract
SELECTBIO is delighted to announce its 4th International Drug Discovery India 2016 Conference and Exhibition. This conference will be held in Hotel Fairfield by Marriott, Bengaluru on September 29-30, 2016. The theme of the conference is
Contact
SelectBio India;     Phone: [7696225050];     Email: sb.jatinkashyap@gmail.com
Topics
Drug Discovery India
32.
 
cGMP and Data Integrity workshop — 2 Day In person seminar on Pharmaceutical cGMP, Data Integrity and FDA Inspections
ID
828950
Dates
29 Sep 2016 - 30 Sep 2016
Location
Mumbai, India
Abstract
A must attend seminar for professionals in Pharmaceutical development and quality control companies, Manufacturers of drug substances (APIs), Finished Products, Contract laboratories and Clinical Research Organizations. This 2 day intensive seminar will provide a review of cGMP regulations with explanations that will demonstrate the benefits of complying with these simple rules.You will learn how to prepare for and what is the appropriate conduct during FDA Inspections. The importance of data integrity and control of electronic records, with particular regards for recent problems with Indian API manufacturers. A comprehensive review of having and following written laboratory investigation procedures. Providing and maintaining adequate audit trails for traceability to your original data.A short role playing exercise will be conducted, which will help you to learn appropriate behavior during regulatory inspections.
Contact
Ajay Kumar;     Phone: [8867363146];     Email: ajay@compliancetrainings.com
Topics
cGMP, data integrity, FDA Inspections, Indian Pharmaceutical, India Drug, FDA Compliance, 2 day In person seminar, API, Laboratory Controls, Process Validation, Quality Protocols
33.
 
DDS USA 2016 — 3rd Annual Drug Discovery USA Congress 2016
ID
821719
Dates
03 Oct 2016 - 04 Oct 2016
Location
San Diego, United States
Abstract
Oxford Global Conferences are proud to present the 3rd Annual Drug Discovery USA Congress, taking place on 3-4 October 2016 in San Diego, USA. Our Congress brings together a host of senior level experts to discuss recent developments in the industry and debate the best strategies and solutions to improve drug discovery going forward.
Contact
Guillaume Alonso;     Phone: [1865248455];     Email: g.alonso@oxfordglobal.co.uk
Topics
Drug Discovery, medicinal chemistry, R&D, peptide drug discovery, strategies for target selection, genomic technologies, discovery research, novel stem cell assays, phenotypic screening strategies, primary cells, disease models, supporting innovation with informatics tools, new data analysis, integration platforms, ideas for efficient data exchange, gene editing.
34.
 
How to Prepare for an FDA Meeting — How to Prepare for an FDA Meeting
ID
829032
Dates
05 Oct 2016 - 06 Oct 2016
Location
Boston, United States
Abstract
How to Prepare for an FDA Meeting

FDA meetings are undeniably one of the most important steps in the development of medicinal products. Whether you are developing a drug, biological product, medical device, generic, diagnostic or anything else regulated by the FDA, it is a good idea to get direct feedback from the FDA about their concerns regarding your product before embarking on expensive and time-consuming development steps. FDA meetings need to be included in all product development strategies. However, the best answers are the one obtained by asking the best questions. Not only the best questions but the conduct of the meeting, management of time, efficiency of response, careful consideration of the answers, all could lead to successful conclusion to the meeting. This workshop would discuss the what, who, when and how of the FDA meetings. Steps from requesting a meeting, preparing and submission of the information package, preparing for the meeting, the conduct of the meeting and follow-up will be discussed using real-life experience and case studies.

Despite a few guidance documents to help sponsors prepare for meetings with the FDA, it is a challenge to understand the most efficient and productive ways to strategize, prepare, conduct, and follow-up for these meetings. There are many misconceptions about the expectations from these meetings both for the sponsor and the FDA, and hence many sponsors fail to get the most benefit from them. Over the years, the FDA has also revised processes and practices for meeting with sponsors.

This two day seminar will provide valuable tips about the logistics, planning, conduct and best practices for all kinds of meetings with the FDA. Throughout the workshop, the author will discuss case studies and examples to highlight the common errors and potential solutions. This workshop contains a collection of practical tips from the instructor’s extensive FDA meeting experience. This one-of-a-kind workshop will provide step-by-step instructions and practical tips to the most productive meeting with FDA for all FDA-regulated organizations.

Learning Objective:

Understanding all kinds of FDA meetings for drugs, biologics, medical devices, and all FDA-regulated meetings

When to and not to do meetings with FDA

Creating, managing and defending rationale for meetings with FDA

Requesting process for FDA meetings

Creating a meeting information package and its regulatory requirements

Logistics of an FDA Meeting

Best practices for FDA meeting follow up

Who Will Benefit:

Regulatory affairs professionals

Senior management executives (CEO, COO, CFO, etc.)

Project managers

Clinical trial specialists

Regulatory compliance associates and managers

People investing in FDA-regulated product development projects

Contact
Peter Brown;     Phone: [+1 410 501 5777];     Email: pbrown@fdamap.com
35.
 
Biomarker Summit Europe 2016
ID
824618
Dates
05 Oct 2016 - 07 Oct 2016
Location
Berlin, Germany
Abstract
The summit will address the latest developments in the biomarker arena from discovery to translation to commercialization. Presentations span across multiple disciplines and cover topics such as discovery and validation strategies, the challenges of clinical translation, novel technologies including next-generation sequencing, companion diagnostics, the health economics value of biomarkers, reimbursement environment, and perspective on cell free biomarkers for disease diagnostics. Scientific data, case studies and discussions will be facilitated by key representatives from pharma, biotech, academia and the public sector.
Contact
Kristen Starkey;     Phone: [6262566405];     Email: infogtcbio@gtcbio.com
Topics
Biomarker, Diagnostics, Cell-Free Biomarkers
Related subject(s)
36.
 
Advanced Protein Aggregation & Characterization
ID
823696
Dates
06 Oct 2016 - 07 Oct 2016
Location
Vienna, Austria
Contact
Andrea Weber;     Phone: [+421257272145];     Email: andrea.weber@fleming.events
Topics
pharmacy, pharma, pharmacology, Drug, Protein, Protein agregates, agregation
37.
 
ComplianceOnline Pharma Summit 2016 – Risk Control and Compliance
ID
819587
Dates
06 Oct 2016 - 07 Oct 2016
Location
Philadelphia, United States
Abstract
Pharmaceutical and biotechnology companies across the globe face unprecedented challenges in the dynamically changing clinical, regulatory and business landscape. Aging populations, chronic diseases, technology and treatment advances are expected to spur health sector growth in 2016. As we approach 2016, it is imperative that leaders in the pharma space understand the trends and shifts happening around them.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
Pharma Summit 2016 - Risk control & Compliance, Biopharma summit 2016, Pharma Conferences, Pharma Events, Biotech Pharma Conclave
38.
 
European Pharmaceutical Market Access and Pricing & Reimbursement
ID
809055
Dates
10 Oct 2016 - 11 Oct 2016
Location
London, United Kingdom
Abstract
SMi Group’s 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement conference returns to London from 10-11 October 2016. The conference is one of the most established in the world, focusing on the changes in pricing and reimbursement and market access. Learn about new strategies, their strengths, weaknesses and future implications.
Contact
Fateja Begum;     Phone: [+44 (0) 20 7827 6184];     Email: fbegum@smi-online.co.uk
Topics
pricing, market access, reimbursement, medicine, regulation, pharmacology,
39.
 
World ADC — World ADC San Diego
ID
803107
Dates
10 Oct 2016 - 13 Oct 2016
Location
San Diego, United States
Abstract
Now in it’s 7th year, World ADC San Diego is the industry’s most definitive antibody drug conjugate forum. Its mission is to enable drug developers to realize the next generation of clinically successful ADC drugs. 
Contact
Jenny Barlow;     Phone: [+1 212 537 5898];     Email: info@hansonwade.com
Topics
Develop Next Generation Clinically Transformative ADCs 2016 is set to be a momentous year for antibody-drug conjugates. Since the start of 2016 alone 3 new ADCs have entered human testing, joining the 54 ADCs already in clinical trials. The ADC industry is on the cusp of realizing the next therapeutic breakthrough. Rapidly diversifying payload, linker and antibody technologies and a surge of novel preclinical ADCs powering towards the clinic have all contributed to this gaining of momentum. Now in it’s 7th year, World ADC San Diego is the industry’s most definitive antibody drug conjugate forum. Its mission is to enable drug developers to realize the next generation of clinically successful ADC drugs. Covering the A-Z of ADCs, World ADC San Diego strikes the balance between distilling ground-breaking science with transformative research that will empower your programs tomorrow. This year, 650 prominent minds from 190 organisations will descend on World ADC San Diego giving you an unparalleled opportunity to foster new connections, catch-up with peers and progress business partnerships.
Event website
40.
 
The Structure of Clinical Trials and Experimental Therapeutics - University of Oxford
ID
749637
Dates
10 Oct 2016 - 14 Oct 2016
Location
Oxford, United Kingdom
Contact
Course Administrator;     Phone: [01865 286955];     Email: expther@conted.ox.ac.uk
Topics
pharmacology, drug development, clinical trials, experimental therapeutics, oxford
41.
 
The Structure of Clinical Trials and Experimental Therapeutics
ID
828774
Dates
10 Oct 2016 - 14 Oct 2016
Location
Oxford, United Kingdom
Abstract
The Structure of Clinical Trials and Experimental Therapeutics course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Oncology Department and the Department for Continuing Education’s CPD Centre, the week will be led by Prof Rachel Kerr and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists.
Contact
Course Administrator;     Phone: [+44(0)1865 286955];     Email: expther@conted.ox.ac.uk
Related subject(s)
42.
 
Cheminformantics for Drug Design
ID
825646
Start date
12 Oct 2016
Location
London, United Kingdom
Abstract
Cheminformatics for Drug Design: Data, Models & Tools Abstract Cheminformatics is a dynamic and rapidly evolving field which is at the heart of modern drug design. This meeting will allow medicinal chemists and scientists involved in drug design to meet and discuss the latest developments and best practices. The meeting topics will include decision-making using data and models, drug design tools for medicinal chemists, software for sharing ideas and collaboration.

The meeting will comprise a high quality programme of plenary lectures, plus both a poster session, and a commercial exhibition.

Contact
SoCI Conference Team;     Phone: [+44 (0)20 7598 1561];     Email: conferences@soci.org
43.
 
Pharma Expo
ID
800937
Dates
12 Oct 2016 - 14 Oct 2016
Location
Saint-Petersburg, Russia
Abstract
The 4th International exhibition of medicines, nutritional and dietary supplements Pharma will take place on 12-14 October 2016 in CEC EXPOFORUM in St. Petersburg.  International Exhibition of medicines, food and dietary supplements Pharma is important industry events for professionals in the medicine and pharmaceutical industry in the Northwest Russia.  The exhibition will be held as part of the St Petersburg International Health Forum.
Event website
44.
 
Training — Diabetes: An Overview
ID
791276
Start date
13 Oct 2016
Location
London, United Kingdom
Abstract
This introductory course provides an overview of the causes, mechanisms and management of diabetes from both a clinical management and a drug development perspective. Our expert speaker will introduce the pathogenesis of the disease and discuss current prevention and treatment options as well as the complications associated with diabetes. The complex inter-relationship with dyslipidaemias, hypertension, obesity and subsequent cardiovascular risk will be examined in some detail.
Contact
Linda Merritt;     Phone: [01727 809917];     Email: courses@healthcare-ed.com
Topics
Clinical presentation and classification, Pathophysiology of T2 diabetes, Treatment options, Micro and macrovascular complications, Prevention of type 2 diabetes – the evidence
45.
 
International Paediatric Pharmaceutical Care Masterclass
ID
799992
Dates
13 Oct 2016 - 15 Oct 2016
Location
London, United Kingdom
Abstract
This is a highly practical masterclass designed by the expert pharmaceutical team at Evelina Children’s Hospital London, part of Guy’s and St Thomas’ NHS Foundation Trust. The masterclass combines case studies, lectures, role plays and patient case reviews at hospital bed sides.
Related subject(s)
46.
 
GCC Pharmacy Congress
ID
773534
Dates
17 Oct 2016 - 20 Oct 2016
Location
Dubai, United Arab Emirates
Abstract
As the GCC countries healthcare moves towards a more patient-centric model, pharmacists are playing an increasingly important role in providing quality care to patients and they are vital members of the healthcare team. Pharmacists play an important role as leaders to improve healthcare outcomes, decrease cost, reduce patient safety risk, optimise medication management systems and align the pharmacy services with the management strategies that measure and reward quality performance. However, the continuing evolution of pharmacist role is tied to numerous challenges including collaboration with the different stakeholders in the medical community, learning about new technologies, remaining competitive in the marketplace, improving patient outcomes, maintaining productivity and more.
47.
 
WTCRF: Using Mixed Methods in Research
ID
807631
Start date
19 Oct 2016
Location
Edinburgh, United Kingdom
Abstract
Through a mixture of lectures and workshops, this one-day course will: - Discuss the long-standing “dichotomy” between quantitative and qualitative methods, and explore how these can be compatible when conducting mixed methods research - Explore the relevance of mixed methods designs for healthcare research and complex interventions - Explore the rationale behind “mixing” methods - Present the key taxonomies of mixed methods designs - Explore the epistemological underpinnings of mixed methods designs (pragmatism) - Provide a wider content for mixed methods research and link this to the Medical Research Council (MRC) Framework, and the principles of Implementation Science - Discuss the practicalities of designing and conducting mixed methods research as well as presenting related findings Date: Wednesday 19th October 2016 Time: 0930-1630 Venue: Seminar Room, Wellcome Trust Clinical research Facility, Western General Hospital, Edinburgh Course Fees: Student Rate: (valid matriculation card required) �40 NHS/Uni Early Bird Rate: (before 31 Aug 2016) �60 NHS/Uni Rate: (after 31 Aug 2016) �80 Industry: �160 For more information, or to book a place, please visit the WTCRF website www.crts.org.uk or contact us at wtcrf.education@ed.ac.uk or 44 (0)131 357 3355 Facebook: https://www.facebook.com/WTCRFEducationProgramme Twitter: @WTCRF_Education
Related subject(s)
48.
 
DIA16 — Discovery Informatics & Analytics Summit 2016
ID
828687
Dates
19 Oct 2016 - 20 Oct 2016
Location
London, United Kingdom
Abstract
This is the only event specifically focused on how to apply advanced informatics and analytics to unlock scientific insights at discovery phase. Transformational strategies and techniques have already been applied at the forefront of discovery informatics, and this year's event will showcase practical use cases of how to power drug discovery using these tools.

Uniting senior scientists from chemistry and biology, Discovery Informatics & Analytics 2016 offers inspirational keynote speeches, practical case studies offering immediate takeaways, interactive discussion sessions, and maximum opportunity to engage and network with colleagues from Europe and beyond.

Contact
Aman Sandhu;     Phone: [2037273100];     Email: aman.sandhu@lbcg.com
Topics
pharma, biotech, informatics, drug discovery
49.
 
RareX — RareX Rare Diseases Conference ft. ICORD
ID
803553
Dates
19 Oct 2016 - 22 Oct 2016
Location
Cape Town, South Africa
Abstract
The purpose of this conference is to provide a global forum for all stakeholders within the Rare Disease field, both locally and abroad, to participate in open discussion, enhance models of best practice and share specialist knowledge around rare diseases and orphan drugs. Incorporating the annual International Conference on Rare Diseases and Orphan Drugs (ICORD) for 2016, RareX has an extended program, to incorporate patients, their families and caregivers as well as support groups and minority groups within the rare disease community.
Contact
Renee;     Phone: [+27 (0) 21 683 2934];     Email: info@rarex.co.za
Topics
Rare Diseases, RareX, Orphan Drugs, Orphan diseases, ICORD, Rare Diseases South Africa
Related subject(s)
Event website
50.
 
NSCA — Nature SciCafe Asia 2016
ID
833467
Start date
24 Oct 2016
Location
Singapore, Singapore
Abstract
Nature SciCafe Asia is an invitation-only biotech forum for investors, entrepreneurs, scientists, government agencies and industry representatives. Only in its second run, the Nature SciCafe Asia has grown to be a series of biotech sessions that aims to develop a strong biotech investment environment in Asia, and connect rising stars in biomedical research to regional investment communities. In the forum, top biomedical investigators, handpicked by Nature Biotechnology and Nature Medicine, will speak of their translational and druggable work. These investigators have been chosen to present their cutting-edge work based on their scientific excellence and on the potential commercial interest of their research to an investor audience. Not forgetting the opportunity to network with influential scientists, investors as well as key representatives from academic institutions, pharmaceutical companies - including J&J Innovation and GSK, and government boards from the Asia Pacific region.
Contact
Nature SciCafe Asia;     Email: admin@naturesciencecafeasia.org
Topics
Nature SciCafe Asia, Nature, SciCafe, biotech, biotechnology, investors, entrepreneurs, scientists, government agencies, pharmaceutical companies, pharma, biomedical research, Nature Biotechnology, Nature Medicine, Nature, translational medicine, translational research, commercial interest, J&J Innovation, GSK, government, government board boards, APAC, Asia Pacific, Asia
51.
 
2nd Antibody Drug Conjugates Conference
ID
820097
Dates
24 Oct 2016 - 25 Oct 2016
Location
Boston, United States
Abstract
We invite you to attend the 2nd Antibody Drug Conjugates Conference, which will take place October 24-25, 2016 in Boston, MA. This event will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain a fresh perspective on the emergence of recent data from ADC clinical trials, new linkers and payloads, personalized healthcare, site specific attachment, and ADC therapeutics. With the field of antibody drug conjugates rapidly expanding and the increasing number of ADC clinical trials, novel therapeutics are emerging. The ADC therapeutic area combines synthetic chemistry with rationale biology and is advancing monoclonal antibody treatments into the realm of precision medicine with improved effectiveness and therapeutic indices.
52.
 
4th Protein Expression, Purification & Characterization Conference
ID
825843
Dates
24 Oct 2016 - 25 Oct 2016
Location
Boston, United States
Abstract
GTCbio is proud to present the 4th Protein Expression, Purification & Characterization Conference to be held on October 24-26, 2016 in Boston, MA. This meeting covers important topics including discussions on the expression of difficult proteins, new methods of purification, extended characterization of production cell lines, expression of difficult proteins, and new efficent analytical tools.
Contact
Kristen Starkey;     Phone: [6262566405];     Email: infogtcbio@gtcbio.com
Topics
Protein Expression, Purification & Characterization
53.
 
7th Euro-Global Summit on Toxicology and Applied Pharmacology
ID
804937
Dates
24 Oct 2016 - 26 Oct 2016
Location
Rome, Italy
Abstract
Euro Toxicology 2016 enables the participants to “Connect, Collaborate and Perceive the Cutting Edge Research Works.” Eurotox aims to foster the spread of the newest advancements in the field of Toxicology and Pharmacology. It bestows a proficient platform to the students to traverse through the top notch research works by the leaders in the field.
Contact
Valentina Leyva;     Phone: [702-508-5197];     Email: valentinaleyva10@gmail.com
Topics
toxicology, pharmacology, euro toxicology 2016, eurotox, pathology, toxicology conference in Europe, genetics, genetic toxicology, toxicity, clinical toxicology, poison, experimental toxicology, clinical toxicologists
54.
 
ICBS2016-Madison — 5th Conference of the International Chemical Biology Society: Translational Chemical Biology
ID
829332
Dates
24 Oct 2016 - 26 Oct 2016
Location
Madison, WI, United States
Abstract
Following successful meetings in Boston, Kyoto, San Francisco and Berlin, ICBS presents its Fifth Annual Conference: Translational Chemical Biology. Twenty-two confirmed invited speakers plus 22 registrants selected from submitted abstracts will present oral presentations in nine sessions including infectious disease, cancer, neurodegenerative disorders, regenerative medicine, imaging and biosensors, epigenetics, natural products, lipids, and the human microbiome. Two poster sessions will be held with evening receptions. ICBS will again recognize three early-stage scientists in a Rising Stars of Chemical Biology session. ICBS2016-Madison will create a vibrant forum for the exchange of information on the latest advances in chemical biology and progress toward translation of these findings in important therapeutic areas.
Contact
Laura Richards;     Phone: [608-2656534];     Email: icbs@union.wisc.edu
Topics
chemical biology, drug discovery, imaging
55.
 
4th Antibody & Protein Therapeutics Conference
ID
820065
Dates
25 Oct 2016 - 26 Oct 2016
Location
Boston, United States
Abstract
We welcome you to the 4th Antibody & Protein Therapeutics Conference, which will be held October 25-26, 2016 in Boston, MA. This conference strives to connect industry and academic researchers in the protein therapeutics field to facilitate discussion on the current state of the industry and discuss recent studies and challenges involved in therapeutic development.
56.
 
IMN — 8th Annual Immunogenicity and Bioassay Summit
ID
811163
Dates
26 Oct 2016 - 28 Oct 2016
Location
Baltimore, MD, United States
Abstract
Following year-on-year success, CHI presents the Eighth Annual Immunogenicity and Bioassay Summit 2016: 3 conferences, FDA presenters plus 40+ additional presentations, 15+ interactive breakout round table and panel discussions, short courses, exhibit/poster hall, and networking opportunities with 250+ delegates. Immunogenicity Prediction & Control is designed to help investigators design and select non-immunogenic products for early-stage decision making, while Immunogenicity Assessment & Clinical Relevance and Optimizing Bioassays for Biologics will enable investigators to overcome the complexities of immunogenicity assessment and bioassays, and develop programs that ensure their products are safe and efficacious, and satisfy regulatory requirements.
Contact
Phone: [781-972-5400];     Email: chi@healthtech.com
Topics
Immunogenicity, Clinical Relevance, Bioassays, Biologics
57.
 
Keystone Symposia: Translational Vaccinology for Global Health
ID
806856
Dates
26 Oct 2016 - 30 Oct 2016
Location
London, United Kingdom
Abstract
The time required to launch new global health vaccines is too long and the late failure rate is unsustainably high. Key barriers include insufficient diversity and quality of preclinical concepts and candidates, immunobiological ignorance, and a lack of understanding of correlates or mechanisms of protection. Root causes include siloed science and linear thinking; poor integration across the discovery/development/delivery ecosystem; and slow entry and limited throughput in early human proof of concept testing. This Keystone Symposia meeting aims to bring together those pioneering novel, creative solutions to these problems of global vaccine discovery and development across the academic/biotech/product development partner/pharma spectrum.
Contact
Attendee Services;     Phone: [1+ 970-262-1230 or 800-253-0685];     Email: info@keystonesymposia.org
Topics
Vaccines Immunology Infectious Diseases Global Health
Related subject(s)
58.
 
FDA’s GMP Expectations for Phase I and First-in-Man Clinical Trials — FDA’s GMP Expectations for Phase I and First-in-Man Clinical Trials
ID
831583
Dates
27 Oct 2016 - 28 Oct 2016
Location
Boston, United States
Abstract
Manufacturing an investigational product for the initial pilot clinical trials could pose a considerable logistical and financial challenge to developers. The first-in-man and pilot clinical trials are usually conducted in very small number of healthy participants with lower doses primarily to establish safety and hence do not need a significant amount of investigational material. The US FDA allows developers to test early stage investigational products under relaxed GMP requirements. The manufacturing requirements for early stage clinical trials are designed to assure adequate quality of the investigational product being tested without the excessive regulatory burden of full-scale GMP manufacturing. This workshop will present the current regulations, guidance documents and regulatory strategies available for manufacturing an early development stage product for Phase I and first-in-man clinical trials. Also discussed will be logistical issues with managing the supply of an early stage investigational product, and requirements for stability testing, storage and shipping, labeling, and documentations. Perspectives for different classes of products will be presented using case studies.
Contact
Peter Brown;     Phone: [+1 410 501 5777];     Email: pbrown@fdamap.com
Topics
FDA GMP Regulations, Phase 1 Clinical trial, GMP Guidance Seminar, IND Submission, GMP for Medical Devices
59.
 
Training — Immunotherapies: An Introductory Overview
ID
791230
Start date
03 Nov 2016
Location
London, United Kingdom
Abstract
This one-day programme provides an introduction to immunotherapies. Immunotherapies are an increasingly important treatment method for a wide range of diseases. This training is developed specifically for pharmaceutical industry personnel and provides a thorough foundation to the subject applicable across therapy areas. It is ideal for individuals with little understanding of immunotherapies and equally beneficial to those with existing basic knowledge enabling further insight to the subject through detailed presentations and discussion with Healthcare’s expert physician faculty.
Contact
Linda Merritt;     Phone: [01727 809917];     Email: courses@healthcare-ed.com
Topics
The immune system – a guide, Introduction to immunotherapies, What goes wrong!, Examples in practice, The future
60.
 
BIO-Europe® 2016 - 22nd Annual International Partnering Conference
ID
796011
Dates
07 Nov 2016 - 09 Nov 2016
Location
Cologne, Germany
Abstract
BIO-Europe® is the preeminent partnering conference for the life sciences, bringing together international decision makers from the biotechnology, pharmaceutical and financial sectors, offering networking opportunities, workshop and panel participation, a high profile exhibition, and private, prescheduled one-to-one meetings.
Contact
Catharine Moreno Finan;     Phone: [+49 89 2388 756-25];     Email: cmoreno@ebdgroup.com
Topics
partnering, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, finance, life science
Related subject(s)
61.
 
Pharma Congress 2016 — World Pharma Congress
ID
829041
Dates
07 Nov 2016 - 09 Nov 2016
Location
Las Vegas, United States
Abstract
World Pharma Congress (Nov 07-09, 2016 Las Vegas, Nevada, USA) Organising Committee welcomes all Pharmaceutical experts around the globe. The conference series aims to provide a forum for worldwide researchers from various areas of Pharmacy, Medical, Health science and Life science by providing a platform for critical analysis of new data, and to share latest cutting-edge research findings and results about all aspects of Pharmaceutical Sciences.
Contact
Andrew Smith;     Phone: [7025085200];     Email: pharmacongress@pharmaceuticalconferences.com
Topics
pharma conferences, pharma summits, pharma events, pharma meetings, pharmaceutical conferences usa, international pharma conferences, drug conferences, babe conferences, babe summit.
62.
 
Biological Therapeutics
ID
828825
Dates
07 Nov 2016 - 11 Nov 2016
Location
Oxford, United Kingdom
Abstract
The Biological Therapeutics course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the course will be led by Professor Len Seymour, Professor of Gene Therapies, and Director of the Section of Clinical Pharmacology at the University of Oxford’s Department of Oncology, and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists.
Contact
Course Administrator;     Phone: [+44(0)1865 286955];     Email: expther@conted.ox.ac.uk
63.
 
E&L Europe 2016 — Extractables & Leachables Europe 2016
ID
808762
Dates
08 Nov 2016 - 10 Nov 2016
Location
Dublin, Ireland
Abstract
The Smithers Rapra Extractables & Leachables conferences, held in both the US and in Europe, are the only two of their kind. Both events deliver a cutting edge analysis of testing techniques and high level insight into the global regulatory landscape, while allowing extensive time for debate and networking.
Contact
Emma Newton;     Phone: [+44 (0) 1372 802016];     Email: enewton@smithers.com
Topics
extractable, leachable, pharmaceutical, packaging, pharmaceutical testing, medical devices, e-cigarettes, packaging testing, mass-spectrometry
64.
 
Gynaecological Oncology — An Update on Topical Issues within Gynaecology Oncology
ID
805553
Start date
09 Nov 2016
Location
South Kensington, London, United Kingdom
Contact
Conference Team;     Phone: [020 7808 2921 / 4];     Email: conferenceteam@rmh.nhs.uk
Topics
Update in Gynaecology Oncology Surgery, Long term GI effects of cancer treatment; Genetics and BRCA testing in Gynaecology Oncology; Update in Gynaecology Clinical Oncology and Nurse led Clinics in Endometrial cancer, A Patient’s perspective, Supporting Women on aspects of motherhood and parenting, Update in Gynaecology Medical Oncology and Nurse led Chemotherapy Clinics, Sexuality post treatment for Gynaecological cancers, Summary and questions session.
Related subject(s)
65.
 
WPE — Inaugural World Preclinical Congress Europe
ID
820709
Dates
14 Nov 2016 - 16 Nov 2016
Location
Lisbon, Portugal
Abstract
The World Preclinical Congress Europe is a key networking event bringing together a global audience involved in preclinical research. It features conferences and short courses that cover the very latest in preclinical strategies and technologies, to enable better and faster decisions in drug discovery. With the broad range of conference's covered, the event offers a diverse cross-disciplinary environment for tackling translational challenges and sharing best practices. It’s where preclinical minds meet discovery technologies to innovate traditional drug discovery by sharing ideas, showcasing new technologies, and fostering new collaborations.
Contact
Phone: [7819725400];     Email: chi@healthtech.com
Topics
medicinal chemistry, lead optimization, drug toxicity, preclinical research, cancer immunotherapy, CRISPR, drug discovery
66.
 
APAMT2016 — Asia Pacific Association of Medical Toxicology 15th Scientific Congress
ID
788237
Dates
17 Nov 2016 - 20 Nov 2016
Location
Singapore, Singapore
Abstract
The Toxicology Society of Singapore warmly invites all of you to join us in the 15th International Scientific Conference of the Asia Pacific Medical Association of Medical Toxicology (APAMT) 2016. This will be the first time that the APAMT conference is held in Singapore. APAMT 2016 promises an exciting experience as we bring together Clinical Toxicologists, Specialists in Poisons Information and researchers and scientists from all over the world, especially from the Asia Pacific to discuss their research, share experience and make new friends. The theme for this conference is “A Toxicologist’s Rendezvous – Meeting of the Disciplines”.

We look forward to welcoming you in Singapore in 2016!

Contact
Conference Secretariat;     Phone: [+65 6570 6280];     Email: info@apamt2016.com
Topics
Toxicology Poison Analysis Chemical Environmental Toxinology
67.
 
Antibodies Targeting GPCRs, Recent Advances and Therapeutic Challenges
ID
830054
Dates
24 Nov 2016 - 25 Nov 2016
Location
Tours, France
Abstract
The conference will be organized as a satellite workshop of the 5th meeting of GDR 3545 on “G Protein-Coupled Receptors (GPCRs) - From Physiology to Drugs” to be held in Tours, Val de Loire (France). The topic of the workshop will focus on new advances and challenges in the development of antibodies targeting GPCRs and their potential applications in clinic. GPCRs represent the largest family of cell surface receptors regulating many human and animal physiological functions. Their implication in human pathophysiology is obvious with about 15% of GPCRs being targeted by 30-40% of the medical drugs commercialized today. Developing therapeutic antibodies directed against GPCRs appears as a promising alternative to selectively and safely modulate their activity. Several speakers from academia and industry considered as leaders in antibody development against GPCRs have accepted to take part in the event. The recent technological strategies used for immunization as well as for development of various antibodies formats (i.e. IgGs, scFv and nanobodies) will be presented. Moreover, the prospective of application of GPCR-selective antibodies in the most important physiological systems such as the central nervous, the immune, and the endocrine systems will be essentially covered.
Topics
GDR, G Protein-Coupled Receptors, GPCRs, antibodies, therapeutic antibodies
Related subject(s)
68.
 
International Congress on Immunology and Vaccine Research
ID
817999
Dates
28 Nov 2016 - 30 Nov 2016
Location
Dubai, United Arab Emirates
Abstract
Immuno congress - 2016 is organized in association with Journal of Immunological Diseases, Disorders and their Prevention, an open access and peer reviewed journal that publishes articles in the field of experimental, clinical immunology, host defense, autoimmune disorders and other related topics. Immunology is a branch of biomedical science that covers the study of all dimensions of immunology. The immunology journal aims in covering the recent technologies and findings in the field of medical science.
Contact
Dhwani Hissaria;     Phone: [1-646-202-2876];     Email: immunocongress2016@clytoaccess.com
Related subject(s)
69.
 
28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
ID
773739
Dates
28 Nov 2016 - 02 Dec 2016
Location
Munich, Germany
Abstract
It is our great pleasure to announce that the   28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics   will take place in Munich.  Hosted by the European Organisation for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI) and the American Association for Cancer Research (AACR), the 2016 Symposium will bring together around 2000 academics, scientists and pharmaceutical industry representatives from across the globe to discuss innovations in drug development, target selection and the impact of new discoveries in molecular biology. As a one-of-a-kind Symposium at the forefront of drug development, it will enable participants to apply the latest findings and knowledge in their work and practice. This edition will also build on the success of the previous symposium which was widely praised for the quality of its programme, inspirational contributions and exclusive insights.
Related subject(s)
70.
 
6th Munich Biomarker Conference - Clinical Practice and Targeted Therapies in Personalized Medicine
ID
789636
Dates
29 Nov 2016 - 30 Nov 2016
Location
Munich, Germany
Abstract
We believe that the challenges of future medicine can only be solved by an interdisciplinary approach. On the one hand, biomarker-driven drug development follows common strategies, on the other hand, only joint efforts will transform the health care system. Therefore, the 6th Munich Biomarker Conference is open to various indications, including, but not limited to, oncology, respiratory diseases, immunology and infection, neurological disorders and orphan diseases.
Contact
BioM Biotech Cluster Development GmbH;     Phone: [+49 (0) 89 / 89 96 79-0];     Email: info@bio-m.org
Topics
Biomarker discovery, validation and clinical use, biomarkers in drug discovery and development, innovative biomarker, technologies, cell-based and cell-free assays, liquid biopsy, biomarkers for immunotherapy, personalized medicine, companion diagnostics and patient selection, combination therapies, patient monitoring, evidence-based medicine
Event website
71.
 
MPMC — MENA Pharmaceutical Manufacturing Congress
ID
802918
Dates
29 Nov 2016 - 01 Dec 2016
Location
Jeddah, Saudi Arabia
Abstract
The MENA Pharmaceutical Manufacturing Congress, will set a unique platform by gathering the pioneers of local and international pharmaceutical companies; CEOs, plant managers, production managers, supply chain managers, quality assurance managers, regulators affairs managers, and engineers. In addition to the leading technology providers who will showcase the latest technologies and developments in pharmaceutical manufacturing. The congress will include case studies, presentations, and interactive panel discussions which will focus on issues such as the obstacles fronting the pharmaceutical industry, the integration between the different concerned entities, and the future of the industry in the region. The conference will also be accompanied by an exhibition that features the latest machinery and technologies used during the different pharmaceutical manufacturing stages, raw materials suppliers, and the regional manufacturers in the country. Join the MENA Pharmaceutical Manufacturing Congress, to gain knowledge and learn about the innovative strategies which are driving the growth of the pharmaceutical manufacturing in the MENA region, and leading the industry towards excellence.
Contact
Yarina;     Phone: [+971 4 361 9616];     Email: info@pharmamanufacturingmena.com
Topics
Pharmaceutical, Manufacturing, Drug, MENA
72.
 
PharmaMed-2016 — International Conference on Medicinal and Pharmaceutical Chemistry
ID
812374
Dates
05 Dec 2016 - 07 Dec 2016
Location
Dubai, United Arab Emirates
Abstract
International Conference on Medicinal and Pharmaceutical Chemistry is going to be held during December 5-7, 2016 at Crowne Plaza, Dubai, UAE. This scientific conference bring upon a new platform to share and discuss all the innovations in the Medicinal and Pharmaceutical Chemistry.
Contact
James Martin;     Phone: [+1-302-231-6959];     Email: pharmamed@madridge.com
Topics
Molecular Modeling and Computer-Aided Drug Design, Drug Discovery from Synthetic and Natural Sources, Drug Design and Drug Delivery, Biopharmaceutics, Chemical Biology and Biophysics, Pharmacology, Toxicology and Pharmacogenomics, Pharmacodynamics and Pharmacokinetics, Pharmaceutical Analysis: Analytical Methods, Pharmaceutical Market, Antibiotics and Anti Cancer Drugs, Advances in Drug Discovery and Medicinal Chemistry, Pharmacology Applications in Medicine.
73.
 
BAC — 3rd Annual Re-Entering Antibacterial Discovery and Development Summit
ID
825075
Dates
07 Dec 2016 - 09 Dec 2016
Location
Boston, United States
Abstract
By holding the Re-Entering Antibacterial Discovery and Development Summit, we at Cambridge Healthtech Institute are trying to contribute to the efforts to overcome the crisis of multidrug resistance, to revive the antibacterial pipeline, and to improve antimicrobial stewardship in the United States and worldwide. This Summit is designed as a forum for knowledge and opinion exchange among all stakeholders participating in discovery and development of new antibacterial agents. It includes several events listed below.
Contact
Pete DeOlympio;     Phone: [781-972-5400];     Email: chi@healthtech.com
Topics
Compound validation, Preclinical development, Clinical phases, Regulatory concerns and pathways, Partnership seeking
74.
 
IMVACS — 11th Annual Immunization & Vaccine Summit
ID
825127
Dates
07 Dec 2016 - 09 Dec 2016
Location
Boston, United States
Abstract
Globally, immunization has proven to be the gateway to health for millions, and continued investment in vaccine development provides a measureable return in reducing the burden of disease and safeguarding human development. Today, more than ever, vaccine technology remains at the forefront of the confrontation against infectious disease. Cambridge Healthtech Institute’s Eleventh Annual Immunization and Vaccine Summit will cover a range of topics in this evolving field, including the latest advancements and applications of vaccine technologies, development of effective vaccine adjuvants, and progress in DNA- and RNA-based vaccines.
Contact
Phone: [781-972-5400];     Email: chi@healthtech.com
Topics
DNA- and RNA- Based Vaccines, Advances in Vaccine Technologies, Vaccine Adjuvants
Related subject(s)
Event website
75.
 
Keystone Symposia: Biobetters and Next-Generation Biologics: Innovative Strategies for Optimally Effective Therapies
ID
830106
Dates
22 Jan 2017 - 26 Jan 2017
Location
Snowbird, Utah, United States
Abstract
The purpose of this meeting is to examine different approaches for treatment of cancer and other diseases (e.g., fibrosis, autoimmunity and inflammatory diseases). The program will provide insights from academic and industry scientists on innovative biologics technologies and treatment strategies for ameliorating disease in an effort to identify synergies and opportunities to cross-fertilize approaches. Furthermore, the meeting includes perspectives from the US Food & Drug Administration and how the outlined strategies will impact the drug review and approval process. The intention is to better inform meeting attendees of current/future strategies for treating disease and best practices for transforming concepts into approved drugs.
Contact
Attendee Services;     Phone: [970-262-1230 or 800-253-0685];     Email: info@keystonesymposia.org
Topics
Cancer, drug discovery, immunology
76.
 
Drug Development, Pharmacokinetics and Imaging
ID
828773
Dates
23 Jan 2017 - 27 Jan 2017
Location
Oxford, United Kingdom
Abstract
The Drug Development, Pharmacokinetics and Imaging module is a one-week module of the MSc in Experimental Therapeutics programme. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the module will be led by Dr Paul Brennan, and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists.
Contact
Course Administrator;     Phone: [+44(0) 01865 286955];     Email: expther@conted.ox.ac.uk
77.
 
Biologistics World Asia 2017
ID
827132
Dates
15 Feb 2017 - 16 Feb 2017
Location
Singapore, Singapore
Abstract
Biologistics World Asia will be the MOST Targeted event in Asia that focuses on cold- chain logistics for biomedical products. Bioplogistics World Asia 2017 will be attended by decision makers from regional and international biopharmaceuticals and biotechnology firms, top CMOs and CROs, government organizations and key global and Asian regulators. It’s your one stop solution to reach out to Asia’s logistics and supply chain industry!
Contact
Andrew Darwitan;     Phone: [+65 3109 0156];     Email: andrew.darwitan@imapac.com
78.
 
Vaccines-2017 — International Conference on Vaccines-2017
ID
811316
Dates
20 Feb 2017 - 22 Feb 2017
Location
Baltimore, United States
Abstract
This scientific conference will bring an opportunity to share potential benefits and limitations of vaccines in preventing and control of infectious and non-infectious diseases thereby enhancing the quality and longevity of life.Vaccines 2017 mainly showcases comprehensive approaches in Vaccines and research, virology. vaccine conference includes Plenary lectures, Keynote lectures and short courses by eminent personalities from around the world in addition to contributed papers both oral and poster presentations
Contact
James Martin;     Phone: [1-302-231-6959];     Email: Vaccines@madrige.com
Topics
Vaccines, virology, Infectious and non infectious diseases, Therapeutic Medicines
79.
 
Frontiers in Cancer Immunotherapy
ID
824414
Dates
27 Feb 2017 - 28 Feb 2017
Location
New York, NY, United States
Abstract
This 2-day scientific symposium will explore emerging findings in basic science, translational research, and clinical studies to improve immunotherapeutic approaches in cancer treatment. The event will convene basic, preclinical, and clinical researchers active in the field of cancer immunotherapy, alongside industry representatives and government stakeholders. Dr. James Allison, Executive Director of the Immunotherapy Platform at the University of Texas MD Anderson Cancer Center and a pioneer in the field of cancer immunotherapy, will commence the conference with a Keynote Address. Plenary speakers will present on an array of topics, including: the evaluation of combination therapy strategies to improve clinical benefit; the development of immune-monitoring strategies for the identification of relevant prognostic and predictive biomarkers; the development of strategies to overcome immune tolerance; and the incorporation of genomics into immunotherapeutic research and clinical trials.
Topics
Immunotherapy, Oncology, Immunology, Therapeutics, Clinical Trials, Vaccines, Diagnostics, Biomarkers, Genomics, Epigenomics, Epigenetics, Drug Discovery, Cancer
Related subject(s)
80.
 
Keystone Symposia - Kinases: Next-Generation Insights and Approaches
ID
825366
Dates
05 Mar 2017 - 09 Mar 2017
Location
Breckenridge, Colorado, United States
Abstract
Decades of both basic and applied research have unequivocally established the importance the kinase family of phosphotransferase enzymes in virtually every aspect of organismal homeostasis. From the initial characterization of ATP-dependent phosphorylation in the liver by Gene Kennedy in 1954, our understanding of the family has grown from the diverse perspectives of enzymology, biochemistry, biophysics, structural biology, genetics, cellular biology, pharmacology and physiology. Importantly, these advancements have yielded transformative therapeutic approaches to disease, most notably in the field of cancer where kinase inhibition is helping to fulfill the promise of precision medicine. Yet even today, our perspectives on the complexity of this class of enzymes continues to evolve, and many of the most exciting advancements in the field are being made by applying modern-day insights and technological approaches to the diverse roles the enzymes can play in health and human disease. This meeting will be devoted to exploring this innovative leading edge of kinase research, and will bring together leading researchers from academic, clinical and pharmaceutical settings to explore and define the new horizons in the field of kinase biology.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
Kinases, Drug Discovery, Kinase Signaling, Kinase Inhibitor
81.
 
Pharmacodynamics, Biomarkers and Personalised Therapy
ID
828827
Dates
06 Mar 2017 - 10 Mar 2017
Location
Oxford, United Kingdom
Abstract
The Pharmacodynamics, Biomarkers and Personalised Therapy course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the week will be led by Dr Elaine Johnstone, Senior Research Fellow at the University of Oxford, and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists, as well as a practical visit to one of Oxford's research laboratories.
Contact
Course Administrator;     Phone: [+44(0)1865 286955];     Email: expther@conted.ox.ac.uk
82.
 
Pharmaceutica 2017 — 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems
ID
833044
Dates
13 Mar 2017 - 15 Mar 2017
Location
London, United Kingdom
Abstract
Pharmaceutica 2017 provides the perfect platform for just this as an interactive and engaging 3-day event: unique in format, content, networking and engagement. The event brings together truly innovative thinkers who are leading the way through trialing new disruptive solutions and rethinking the conventional formulation and delivery mind-set and will help you to better understand how to develop the right formulation and delivery strategy with a strong scientific, clinical and commercial mind set and how innovative scientific techniques, emerging technologies and innovative devices can transform formulation and drug delivery.
Contact
Renaldo Howell;     Phone: [+1 702 508 5200];     Email: renaldohowell179@gmail.com
Topics
Pharmaceutics, Drug Delivery, Targeted Drug Delivery, Formulation, Pharmaceutical nanotechnology, nanomedicine, smart drug delivery
83.
 
Keystone Symposia - Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity
ID
825180
Dates
19 Mar 2017 - 22 Mar 2017
Location
Tahoe City, California, United States
Abstract
There are fundamental aspects of metabolic homeostasis that are regulated differently in males and females, and influence both the development of diabetes and obesity and the response to pharmacological intervention. Still, most preclinical researchers avoid studying female rodents due to the added complexity of research plans. The consequence is the generation of data that risks being relevant to only half of the population. This is a timely moment to study sex differences in diseases as NIH leadership has asked scientists to consider sex as a biological variable in preclinical research, to ensure that women get the same benefit of medical research as men. The goal of this meeting is to fill a need in the scientific community by connecting interdisciplinary groups of scientists who normally would not have an opportunity to interact. This group includes investigators studying sex differences, the role of sex hormones, the systems biology of sex and the genetic contribution of sex chromosomes to metabolic homeostasis and diseases. Leaders of the pharmaceutical industry will present their views on sex-specific drug discovery. The meeting is expected to generate new knowledge and ideas on the importance of gender biology and medicine from a molecular standpoint to the population level, and to provide the methods to study them. It is intended to be a catalyst of a process that will lead to gender-specific treatments of metabolic diseases.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
sex, gender, metabolic homeostasis, diabetes, obesity, sex differences, estrogens, androgen, drug design, gender-specific medicine, metabolomics, genetics
Related subject(s)
84.
 
Keystone Symposia - Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology
ID
825241
Dates
19 Mar 2017 - 23 Mar 2017
Location
Whistler, British Columbia, Canada
Abstract
The fields of cancer immunology and immunotherapy continue to make great strides in providing both a comprehensive understanding of the basic mechanisms underlying tumor-immune system interactions and applying this knowledge to the development of effective immune-based cancer therapies. This Keystone Symposia meeting is organized to highlight recent insights into the complex roles of immune components and pathways in controlling or alternatively promoting cancer and to showcase recent uses of cancer vaccines, checkpoint blocking strategies, adoptive cell therapies and cellular engineering approaches, either as mono- or combinatorial therapies, that have resulted in durable, effective and safe therapeutic responses to an increasing number of cancer patients. Part of the meeting will also focus on new, developing technologies that are likely to expand our capacity to monitor the effects of cancer immunotherapy with a precision, refinement and at a level that has not been possible in the past.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
cancer immunology, cancer immunotherapy, immunosuppressive cells, tumor microenvironment, immune checkpoints, combinatorial approaches, cancer vaccines, inflammation, cellular engineering, nex-gen technologies
Related subject(s)
85.
 
8th Annual Biotherapeutics Analytical Summit
ID
829772
Dates
20 Mar 2017 - 23 Mar 2017
Location
Bethesda, United States
Abstract
Today’s complex biologics formats and ever increasing regulatory demands necessitates that companies come up with the most efficient, accurate and robust analytical methods to characterize a molecule; find the most effective tools to assess the molecule’s physico-chemical properties to optimize its druggability and developability, and to ensure that the end product is consistently safe and efficacious when comparing between batches or between biosimilars and innovators. When it comes to batch-to-batch variation, as the saying goes, “process is the product” – process analytics and quality control are thus of biggest concern to manufacturers and regulators alike.
Contact
Bethany Gray;     Phone: [781-972-5400];     Email: chi@healthtech.com
86.
 
Keystone Symposia - HIV Vaccines
ID
825170
Dates
26 Mar 2017 - 30 Mar 2017
Location
Steamboat Springs, Colorado, United States
Abstract
Despite great progress in preventing and treating HIV, new infections continue to plague communities around the world, and the need for an HIV vaccine is as urgent as ever. Several large cohorts of HIV-infected individuals have enabled tremendous advances over the past five years in understanding immune responses to natural HIV infection. These advances have included the isolation of broad and potent anti-HIV antibodies, defining their developmental pathways, the generation of native-like Env trimers for immunization, and high-resolution structures of the envelope glycoprotein in complex with bnAbs. By 2017, many of these discoveries will have enabled new concepts to transition into human clinical trials, including passive monoclonal antibody therapy and novel immunization approaches. These platforms, incorporating improved technology for monitoring immune responses, will drive major advances in the vaccine field. This HIV Vaccines meeting will present the latest results from human clinical studies, along with the cutting-edge basic science behind such trials to highlight approaches that may lead to an HIV vaccine, and also reveal the molecular underpinnings of B and T cell-mediated immunity.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
HIV Vaccines, HIV, natural infection, transmission biology, immunogen platforms, b-cells, t-cells,
Related subject(s)
87.
 
MESMAP-3 — The Third Mediterranean Symposium on Medicinal and Aromatic Plants
ID
811581
Dates
13 Apr 2017 - 16 Apr 2017
Location
Girne (Kyrenia), Cyprus, Turkey
Related subject(s)
Event website
88.
 
Pharma Tech 2017 — International Conference and Exhibition on Pharmaceutical Development and Technology
ID
828986
Dates
24 Apr 2017 - 26 Apr 2017
Location
Dubai, United Arab Emirates
Abstract
ConferenceSeries LLC is a renowned organization that organizes highly notable pharmaceutical conferences and healthcare conferences throughout the globe. ConferenceSeries LLC invites all the participants from all over the world to attend “International Conference and Exhibition on Pharmaceutical Development and Technology ”during April 24-26, 2017 Dubai, UAE.This includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Pharma Tech 2017 is a latest technological platform to aid efficient drug discovery and development. These platforms range from vast chemical libraries, ultra-high throughput screening and huge genetic databases in discovery, to predictive toxicology platforms and even deep-seated knowledge of particular therapeutic areas in development. New research platforms designed to help its teams of investigators focus on a set of key strategic initiatives that will help guide their multibillion-dollar drug development program to advance new medicines that can get ahead of a disease and prevent it from taking a toll.
Contact
Mythrei Syria;     Phone: [+1-702-508-5200];     Email: pharmatech@pharmaceuticalconferences.com
Topics
Pharmaceutical Technology, Pharmaceutical Technology Conferences, Pharma Tech Meetings, Pharma Tech Symposiums, Pharma Tech Exhibitions, Pharma Tech 2017 Conferences, Pharma Tech Conferences Dubai, Pharma Tech meetings USA, Pharma Tech Conferences euro
89.
 
Keystone Symposia - Modeling Viral Infections and Immunity
ID
825397
Dates
01 May 2017 - 04 May 2017
Location
Estes Park, Colorado, United States
Abstract
Viral infection modeling has provided insights into the pathogenesis and treatment of HIV, HCV, HSV-2, CMV and other viruses. It has had impact in revealing the lifespan of infected cells, how rapidly virus is produced and cleared from the circulation, and the means for evaluating the effectiveness of antiviral treatments. HIV remains a global health threat and there is great interest in revealing features of the main HIV reservoir, latently infected cells and mechanisms of reducing the size of this reservoir by pharmacological means. Other important gaps in knowledge revolve around the cell-mediated and humoral immune responses to HIV, important for generating vaccines and broadly neutralizing antibodies as therapeutics, topics that will be discussed. Further, viral infections generally occur in tissues and thus the meeting will discuss imaging techniques and methods of modeling and analyzing spatial infection data, the role of tissue-resident memory cells, and important features of immune regulation, such as immune exhaustion, cytokine signaling between cells, and viral subversion of innate responses and escape from adaptive responses. The meeting will highlight what we believe are significant hurdles to curing viral infections and will bring together experimental virologists, physician scientists and modelers of various types and experience, groups that do not normally meet. It should foster new collaborations between experimentalists and theoreticians, and between theoreticians working on different viral infections or different aspects of viral infections, as well as help young scientists formulate new research directions and make connections with established senior scientists.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
modeling viral infections, immunity, viral infection, Modeling Immune Regulation, HIV, Modeling Cellular Immune Responses, Spatial Aspects of Infection
Related subject(s)
90.
 
Adverse Drug Reactions, Drug Interactions and Pharmacovigilance
ID
828826
Dates
08 May 2017 - 12 May 2017
Location
Oxford, United Kingdom
Abstract
The Adverse Drug Reactions, Drug Interactions and Pharmacovigilance course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the teaching will be led by Dr Michael Theodorakis, Radcliffe Department of Medicine, University of Oxford, and will feature face-to-face lectures and tutorials from some of the country's leading clinicians and scientists.
Contact
Course Administrator;     Phone: [+44(0)1865 286955];     Email: expther@conted.ox.ac.uk
91.
 
Biologistics World Korea 2017
ID
827219
Dates
23 May 2017 - 24 May 2017
Location
Seoul, South Korea
Abstract
Biologistics World Korea is the MOST Targeted event in Korea that focuses on supply chain management and logistics for biologics and vaccines. Located in Singapore, the prime logistics hub of Korea, the programme promises to bring together key opinion leaders, rising players and market experts to discuss, debate and brainstorm on the most pertinent issues affecting Korea’s logistics network within a global context!
Contact
Andrew Darwitan;     Phone: [+65 3109 0156];     Email: andrew.darwitan@imapac.com
92.
 
10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems
ID
831623
Dates
13 Jun 2017 - 15 Jun 2017
Location
London, United Kingdom
Contact
Renaldo Hawell;     Email: renaldohowell179@gmail.com
Topics
Pharmaceutics/Formulation/Drug Delivery/Vaccine/Novel Drug Delivery
93.
 
Antibodies & Complement: Effector Functions, Therapies & Technologies
ID
781802
Dates
20 Jun 2017 - 23 Jun 2017
Location
Albufeira, Portugal
Abstract
The antibody response and the complement system are major effector arms of the immune system. Both have been involved in a plethora of pathological conditions – including autoimmunity, allergy, infections and cancer- and regulate, mainly through their receptors (FcR and CR respectively) cell activation, migration, survival but also metabolism. As the portfolio of antibody- and complement-effector function grow, high-end technological solutions are developed and novel therapeutic applications are proposed.

This Zing conference will focus attention on key advances in both fields with the aim at fostering discussions between antibody experts and complement experts.

Related subject(s)
94.
 
How to do Research on Therapeutic Interventions: Protocol Preparation
ID
828776
Dates
03 Jul 2017 - 07 Jul 2017
Location
Oxford, United Kingdom
Abstract
The How to do Research on Therapeutic Interventions: Protocol Preparation course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the teaching will be led by Dr Grant D Vallance, Information Manager at the Oxford University Hospitals NHS Trust, and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists.
Contact
Course Administrator;     Phone: [+44(0)1865 286955];     Email: expther@conted.ox.ac.uk
95.
 
Asia Pharma 2017 — 10th Asia-Pacific Pharma Congress
ID
827445
Dates
24 Jul 2017 - 26 Jul 2017
Location
Melbourne, Australia
Abstract
Asia Pharma 2017 is a perfect platform for scientists, decision-makers and students to come together, compare findings, and discuss the science of the future. Share your research with an engaged audience of your peers from around the globe; learn from scientific trail blazers who are designing more sustainable processes; find out how Pharmaceutical innovations are inspiring new businesses and product lines. Pharmaceutical sciences focus on the physiology and chemistry controlling drug therapeutic action in modern medicine. Often confused with pharmacy practice, pharmaceutics is distinct in its research and development emphasis, contributing important technologies and scientific bases for drug delivery to patients. Over half of newly discovered drug candidates cannot be commercialized without further drug delivery and formulation assistance. Researchers trained in pharmaceutics integrate a broad working knowledge of diverse scientific disciplines: from fundamental studies of drug physiochemical properties and bioactive molecules to mechanisms of various physiological processes that impact drug delivery to specific biological sites of action and, therefore, their therapeutic effectiveness. Increasing awareness of the complexity of the drug delivery process in living systems means that researchers in pharmaceutics today must maintain breadth and depth in physical chemistry, physical organic chemistry, bioengineering, nanotechnology and the life sciences in order to solve research problems that require integration basic science concepts from multiple disciplines with medical applications.
Contact
Robert Brown;     Phone: [17025085200];     Email: asiapharma@pharmaceuticalconferences.com
Topics
Regulatory Affairs, Intellectual Property Rights, Pharmacognosy and Phytochemistry, Advancements in Pharmaceutics, Trends in Nanotechnology, Industrial Pharmacy, Pharmacological Studies, Pharmaceutical Chemistry, Pharmaceutical Analysis, Pharmaceutical Microbiology, Pharmaceutical Biotechnology, Biochemistry and Molecular Biology, Clinical Pharmacy, Hospital Pharmacy, Pharmaceutical Care & Health Systems, Pharma Compliance.
5th annual Cancer Vaccines conference
7th annual Biosimilars Europe conference
Superbugs & Superdrugs USA Conference & Exhibition

Find a hotel

Booking.com

Good to know...

You can advertise your event or services in this space.

Last updated: 19 August 2016